Original research
by
Rudolph, Kara E. et al
Release Date
2022
Geography
USA
Language of Resource
English
Full Text Available
No
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
We estimated the extent to which different dosing strategies would affect risk of relapse over 12 weeks of treatment, separately for BUP-NX and methadone.
Findings/Key points
For BUP-NX, increasing dose following the hybrid strategy both resulted in the lowest risk of relapse. For methadone, holding dose constant resulted in greatest risk of relapse; the other three strategies performed similarly.
Design/methods
Secondary analysis of three trials
Keywords
Substitution/OAT
Outcomes
